CARDURA

This brand name is authorized in United States. It is also authorized in Cyprus, Ecuador, Estonia, Hong Kong SAR China, Ireland, Italy, Lithuania, Malta, Mexico, Netherlands, Nigeria, Poland, Romania, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug CARDURA contains one active pharmaceutical ingredient (API):

1	Doxazosin UNII 86P6PQK0MU - DOXAZOSIN MESYLATE
	Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure.
	Read more about Doxazosin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CARDURA Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
CARDURA XL Extended-release tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02CA04	Doxazosin	C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29265-06-10, 29690-03-11, 30071-12-11
EE	Ravimiamet	1028214, 1028225, 1129799, 1129801
GB	Medicines & Healthcare Products Regulatory Agency	13549, 13948, 143440, 14678, 14693, 161462, 180535, 302668, 377176
HK	Department of Health Drug Office	31169, 31170, 31171, 45161, 45162
IE	Health Products Regulatory Authority	16101, 16122, 16160, 16179, 16202, 16257
IT	Agenzia del Farmaco	026821013, 026821025, 039353014, 039353026, 039353038, 039353040, 039462015, 039462027, 039462039, 039462041, 040734016, 040734028, 041749019, 041749021, 043633027, 043633039, 043639018, 044488029, 044488031, 044488043
LT	Valstybinė vaistų kontrolės tarnyba	1002954, 1002955, 1003517, 1004145, 1008454, 1012028, 1058253, 1072502, 1072503, 1076855, 1083116, 1089478
MT	Medicines Authority	AA1396/00303, AA1396/00304, AA1438/07601, AA908/17901, AA908/17902, MA1396/00301, MA1396/00302
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	184M2012, 354M89
NG	Registered Drug Product Database	A4-0272
NL	Z-Index G-Standaard, PRK	53589, 53597
PL	Rejestru Produktów Leczniczych	100013011, 100013028, 100013034, 100088204, 100088210
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67252001, W67252002
SG	Health Sciences Authority	05014P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532011114, 8699532011121, 8699532015976, 8699532015983, 8699532019141, 8699532019158, 8699532034885, 8699532034892, 8699532035486, 8699532035493
US	FDA, National Drug Code	0049-2710, 0049-2720, 0049-2750, 0049-2760, 0049-2770, 0049-2780
ZA	Health Products Regulatory Authority	32/7.1/0556, 32/7.1/0557